India to Belarus: Pazopanib Export Trade Route
India has recorded 2 verified shipments of Pazopanib exported to Belarus, representing a combined trade value of $150.1K USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $75.0K USD. The leading Indian exporter is SP ACCURE LABS PRIVATE LIMITED , which accounts for 51% of total export value with 1 shipments worth $76.1K USD. On the buying side, TISHAS ADDITIONAL LIABILITY COMPANY is the largest importer in Belarus with $76.1K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Belarus Pazopanib corridor is one of India's established pharmaceutical export routes, with 2 shipments documented worth a combined $150.1K USD. The route is dominated by SP ACCURE LABS PRIVATE LIMITED , which alone accounts for roughly 51% of all export value, reflecting the consolidated nature of India's pazopanib manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $75.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during July–September, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 31.5%, placing it at rank #4 among India's top pazopanib export destinations globally.
On the import side, key buyers of Indian pazopanib in Belarus include TISHAS ADDITIONAL LIABILITY COMPANY , TISHAS ADDITIONAL LIABILITY COMPANY. TISHAS ADDITIONAL LIABILITY COMPANY is the single largest importer with 1 shipments valued at $76.1K USD.
Route Characteristics
- Average transit28 days
- Peak seasonQ3
- Primary modeMulti-modal
- Top portHYDERABAD ACC (INHYD4)
Market Position
- Global rank#4
- Annual growth+31.5%
- Demand growth+28.1%
- Regulatory ease68/100
Top 10 Indian Pazopanib Exporters to Belarus
Showing top 10 of 2 Indian suppliers exporting Pazopanib to Belarus, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SP ACCURE LABS PRIVATE LIMITED Avg $76.1K per shipment | 1 | $76.1K | 50.7% |
| 2 | SP ACCURE LABS PRIVATE LIMITED Avg $74.0K per shipment | 1 | $74.0K | 49.3% |
This table shows the top 10 of 2 Indian companies exporting pazopanib to Belarus, ranked by total trade value. The listed exporters are: SP ACCURE LABS PRIVATE LIMITED , SP ACCURE LABS PRIVATE LIMITED. SP ACCURE LABS PRIVATE LIMITED is the dominant supplier with 1 shipments worth $76.1K USD, giving it a 51% market share.
Top 10 Pazopanib Importers in Belarus
Showing top 10 of 2 known buyers in Belarus receiving Pazopanib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian pazopanib in Belarus include TISHAS ADDITIONAL LIABILITY COMPANY , TISHAS ADDITIONAL LIABILITY COMPANY. The largest importer is TISHAS ADDITIONAL LIABILITY COMPANY , accounting for $76.1K USD across 1 shipments — representing 51% of all pazopanib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TISHAS ADDITIONAL LIABILITY COMPANY | 1 | $76.1K | 50.7% |
| 2 | TISHAS ADDITIONAL LIABILITY COMPANY | 1 | $74.0K | 49.3% |
Top 10 Pazopanib Formulations Imported by Belarus
Showing top 10 of 2 product formulations shipped on the India to Belarus Pazopanib route, ranked by trade value
Belarus imports a wide range of pazopanib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PAZO SPAN 400 PAZOPANIB TABLETS 400MG PA — accounts for $76.1K USD across 1 shipments. A total of 2 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PAZO SPAN 400 PAZOPANIB TABLETS 400MG PA | 1 | $76.1K | 50.7% |
| 2 | PAZO SPAN 400 PAZOPANIB TABLETS 400MG PACK SIZE 30 S PACK 1X30 | 1 | $74.0K | 49.3% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 67% sea for bulk, 17% air for urgent orders.
Top Ports of Origin
HYDERABAD ACC (INHYD4) handles the highest volume with 1 shipments. Transit time averages 28 days by sea.
Market Dynamics
India's pazopanib exports to Belarus are driven primarily by a handful of large-scale manufacturers. SP ACCURE LABS PRIVATE LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Belarus benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SP ACCURE LABS PRIVATE LIMITED , SP ACCURE LABS PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $75.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as pazo span 400 pazopanib tablets 400mg pack size 30 s pack 1x30, suggesting that buyers in Belarus tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TISHAS ADDITIONAL LIABILITY COMPANY is the largest importer with 1 shipments worth $76.1K USD — representing 51% of all pazopanib imports from India on this route.
Route Statistics
- Trade Volume
- $150.1K
- Avg. Shipment
- $75.0K
- Suppliers
- 2
- Buyers
- 2
- Transit (Sea)
- ~28 days
- Annual Growth
- +31.5%
Other Pazopanib Routes
Unlock the Full India to Belarus Pazopanib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 2 shipments on this route.
Frequently Asked Questions — India to Belarus Pazopanib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Pazopanib to Belarus?
The leading Indian exporters of Pazopanib to Belarus are SP ACCURE LABS PRIVATE LIMITED , SP ACCURE LABS PRIVATE LIMITED. SP ACCURE LABS PRIVATE LIMITED holds the largest market share at approximately 51% of total trade value on this route.
Q What is the total value of Pazopanib exports from India to Belarus?
India exports Pazopanib to Belarus worth approximately $150.1K USD across 2 recorded shipments. The average value per shipment is $75.0K USD.
Q Which ports does India use to ship Pazopanib to Belarus?
The most active port of origin is HYDERABAD ACC (INHYD4) with 1 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 67% of shipments going by sea and 17% by air.
Q How long does shipping take from India to Belarus for Pazopanib?
The average transit time for Pazopanib shipments from India to Belarus is approximately 28 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Belarus Pazopanib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 31.5% with demand growth tracking at 28.1%. The route is ranked #4 among India's top Pazopanib export destinations globally.
Q How many suppliers are active on the India to Belarus Pazopanib route?
There are currently 2 active Indian suppliers exporting Pazopanib to Belarus. The market is moderately concentrated with SP ACCURE LABS PRIVATE LIMITED accounting for 51% of total shipment value.
Q Who are the main importers of Pazopanib from India in Belarus?
The leading importers of Indian Pazopanib in Belarus include TISHAS ADDITIONAL LIABILITY COMPANY , TISHAS ADDITIONAL LIABILITY COMPANY. TISHAS ADDITIONAL LIABILITY COMPANY is the largest buyer with 1 shipments worth $76.1K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Belarus export trade corridor identified from Indian Customs (DGFT) records for Pazopanib.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 2 importers in Belarus matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 2 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists